William Petros Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center West Virginia University School of Medicine Biography Publications Institution JoVE Articles William Petros has not added a biography. If you are William Petros and would like to personalize this page please email our Author Liaison for assistance. Publications A Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients Antimicrobial Agents and Chemotherapy. Jan, 2016 | Pubmed ID: 26824940 Clinical Pharmacology of an Atrasentan and Docetaxel Regimen in Men with Hormone-refractory Prostate Cancer Cancer Chemotherapy and Pharmacology. May, 2014 | Pubmed ID: 24619498 Sibling Donor and Recipient Immune Modulation with Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Dec, 2013 | Pubmed ID: 24166529 Three-dimensional Hierarchical Plasmonic Nano-architecture Enhanced Surface-enhanced Raman Scattering Immunosensor for Cancer Biomarker Detection in Blood Plasma ACS Nano. Jun, 2013 | Pubmed ID: 23659430 Duration of Cisplatin Excretion in Breast Milk Journal of Human Lactation : Official Journal of International Lactation Consultant Association. Nov, 2013 | Pubmed ID: 23492761 Effects of Tobacco Smoking and Nicotine on Cancer Treatment Pharmacotherapy. Oct, 2012 | Pubmed ID: 23033231 Development and Utilization of a Combined LC-UV and LC-MS/MS Method for the Simultaneous Analysis of Tegafur and 5-fluorouracil in Human Plasma to Support a Phase I Clinical Study of Oral UFT®/leucovorin Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. Jun, 2012 | Pubmed ID: 22565063 Melphalan Exposure Induces an Interleukin-6 Deficit in Bone Marrow Stromal Cells and Osteoblasts Cytokine. May, 2012 | Pubmed ID: 22356805 Correlations Among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 Revealed by Gene Signatures of Histological Subtypes of Patients with Epithelial Ovarian Cancer Oncology Reports. Jan, 2012 | Pubmed ID: 21971700 A Phase I Multicenter Study of Continuous Oral Administration of Lonafarnib (SCH 66336) and Intravenous Gemcitabine in Patients with Advanced Cancer Cancer Investigation. Nov, 2011 | Pubmed ID: 22011284 A Phase I Study of Bevacizumab (B) in Combination with Everolimus (E) and Erlotinib (E) in Advanced Cancer (BEE) Cancer Chemotherapy and Pharmacology. Feb, 2011 | Pubmed ID: 21079958 Phase I and Pharmacokinetic Study of Lonafarnib, SCH 66336, Using a 2-week On, 2-week off Schedule in Patients with Advanced Solid Tumors Cancer Chemotherapy and Pharmacology. Feb, 2011 | Pubmed ID: 20972873 Meeting Report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010 Journal of Immunotherapy (Hagerstown, Md. : 1997). Sep, 2010 | Pubmed ID: 20664361 A Phase I Dose-escalation Study of Imatinib Mesylate (Gleevec/STI571) Plus Capecitabine (Xeloda) in Advanced Solid Tumors Anticancer Research. Apr, 2010 | Pubmed ID: 20530436 HPV Infection and EGFR Activation/alteration in HIV-infected East African Patients with Conjunctival Carcinoma PloS One. 2010 | Pubmed ID: 20498858 Phase I Dose Escalation Study of Gemcitabine Plus Irinotecan in Advanced Solid Tumors Anticancer Research. Dec, 2009 | Pubmed ID: 20044630 Building a Statewide Clinical Trials Network for Cancer Care in West Virginia The West Virginia Medical Journal. Oct, 2009 | Pubmed ID: 19999259 Enterohepatic Recirculation Model of Irinotecan (CPT-11) and Metabolite Pharmacokinetics in Patients with Glioma Cancer Chemotherapy and Pharmacology. Feb, 2009 | Pubmed ID: 18496691 A Phase I-II Study of Docetaxel and Atrasentan in Men with Castration-resistant Metastatic Prostate Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2008 | Pubmed ID: 18829508 Dehydroalanine Analog of Glutathione: an Electrophilic Busulfan Metabolite That Binds to Human Glutathione S-transferase A1-1 The Journal of Pharmacology and Experimental Therapeutics. Dec, 2008 | Pubmed ID: 18791061 Phase I Evaluation of Gemcitabine, Mitoxantrone, and Their Effect on Plasma Disposition of Fludarabine in Patients with Relapsed or Refractory Acute Myeloid Leukemia Leukemia & Lymphoma. Aug, 2008 | Pubmed ID: 18766965 Isolated Limb Infusion for In-transit Malignant Melanoma of the Extremity: a Well-tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion Annals of Surgical Oncology. Aug, 2008 | Pubmed ID: 18528730 Metabolism of the Cysteine S-conjugate of Busulfan Involves a Beta-lyase Reaction Drug Metabolism and Disposition: the Biological Fate of Chemicals. Aug, 2008 | Pubmed ID: 18474673 A Phase I Study of UFT/leucovorin, Carboplatin, and Paclitaxel in Combination with External Beam Radiation Therapy for Advanced Esophageal Carcinoma International Journal of Radiation Oncology, Biology, Physics. Mar, 2008 | Pubmed ID: 17881149 A Phase I Study of the Safety and Pharmacokinetics of Edotecarin (J-107088), a Novel Topoisomerase I Inhibitor, in Patients with Advanced Solid Tumors Cancer Chemotherapy and Pharmacology. Jan, 2007 | Pubmed ID: 16819636 Influence of Garlic (Allium Sativum) on the Pharmacokinetics of Docetaxel Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2006 | Pubmed ID: 16899612 Phase I Trial of Doxorubicin-containing Low Temperature Sensitive Liposomes in Spontaneous Canine Tumors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2006 | Pubmed ID: 16818699 Phase I Trial of Intrathecal Spartaject Busulfan in Children with Neoplastic Meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004) Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2006 | Pubmed ID: 16533779 A Phase I Study of Eniluracil/5-FU in Combination with Radiation Therapy for Potentially Resectable And/or Unresectable Cancer of the Pancreas and Distal Biliary Tract Cancer Investigation. Feb, 2006 | Pubmed ID: 16466986 Consolidation with High-dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-free Survival in Hormone-insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-dose Chemotherapy Alone Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Feb, 2006 | Pubmed ID: 16443517 Associations Between Drug Metabolism Genotype, Chemotherapy Pharmacokinetics, and Overall Survival in Patients with Breast Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Sep, 2005 | Pubmed ID: 16087946 Pharmacogenomics in Cancer Therapy: is Host Genome Variability Important? Trends in Pharmacological Sciences. Sep, 2004 | Pubmed ID: 15559247 Intraindividual Variability in Busulfan Pharmacokinetics in Patients Undergoing a Bone Marrow Transplant: Assessment of a Test Dose and First Dose Strategy Anti-cancer Drugs. Jun, 2004 | Pubmed ID: 15166618 A Phase I Trial of Preoperative Eniluracil Plus 5-fluorouracil and Radiation for Locally Advanced or Unresectable Adenocarcinoma of the Rectum and Colon International Journal of Radiation Oncology, Biology, Physics. Mar, 2004 | Pubmed ID: 14967434 Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-day Schedule to Patients with Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Dec, 2003 | Pubmed ID: 14645433 Marked Variability of Melphalan Plasma Drug Levels During Regional Hyperthermic Isolated Limb Perfusion American Journal of Surgery. Nov, 2003 | Pubmed ID: 14599607 Introduction: Pegfilgrastim, a New Era in the Management of Chemotherapy-induced Neutropenia Pharmacotherapy. Aug, 2003 | Pubmed ID: 12921215 Initial Clinical Trial of Oral TAC-101, a Novel Retinoic Acid Receptor-alpha Selective Retinoid, in Patients with Advanced Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2002 | Pubmed ID: 12177113 Steady-state Pharmacokinetics of Lamivudine in Human Immunodeficiency Virus-infected Patients with End-stage Renal Disease Receiving Chronic Dialysis Antimicrobial Agents and Chemotherapy. Aug, 2002 | Pubmed ID: 12121909 Analysis of Age, Estimated Creatinine Clearance and Pretreatment Hematologic Parameters As Predictors of Fludarabine Toxicity in Patients Treated for Chronic Lymphocytic Leukemia: a CALGB (9011) Coordinated Intergroup Study Cancer Chemotherapy and Pharmacology. Jul, 2002 | Pubmed ID: 12111110 A Phase I Pharmacokinetic and Translational Study of the Novel Vascular Targeting Agent Combretastatin A-4 Phosphate on a Single-dose Intravenous Schedule in Patients with Advanced Cancer Cancer Research. Jun, 2002 | Pubmed ID: 12067983 Association of High-dose Cyclophosphamide, Cisplatin, and Carmustine Pharmacokinetics with Survival, Toxicity, and Dosing Weight in Patients with Primary Breast Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2002 | Pubmed ID: 11895898 Phase I Evaluation of Prolonged-infusion Gemcitabine with Mitoxantrone for Relapsed or Refractory Acute Leukemia Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2002 | Pubmed ID: 11821447 Modellering Chemotherapy Resistent Leukemi William L. Slone*1, Blake S. Moses*1, Rebecca Evans1, Debbie Piktel1, Karen H. Martin1,2, William Petros1, Michael Craig1, Laura F. Gibson1,3 1Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, 2Department of Neurobiology and Anatomy, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, 3Department of Microbiology, Immunology and Cell Biology, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine Medicine
Modellering Chemotherapy Resistent Leukemi William L. Slone*1, Blake S. Moses*1, Rebecca Evans1, Debbie Piktel1, Karen H. Martin1,2, William Petros1, Michael Craig1, Laura F. Gibson1,3 1Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, 2Department of Neurobiology and Anatomy, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, 3Department of Microbiology, Immunology and Cell Biology, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine Medicine